VINIF.2023.DA139 – Automated production of CRISPR-Cas9 gene-edited CD34+ hematopoietic stem cells for clinical treatment of Beta thalassemia

project manager image
Principle Investigator
Dr. Dao Thi Mai Lan
Host Organization
Vinmec Research Institute of Stem cell and Gene Technology
project manager image
Principle Investigator
Dr. Dao Thi Mai Lan
Host Organization
Vinmec Research Institute of Stem cell and Gene Technology

Tags

Tags